ALLOSTATIN® is a lyophilized peptide that has a structural similarity to insect alloferons and mammalian immunoglobulins

Action mechanism

A selective activator of cytotoxic cells in the human immune system. In the presence of Allostatin®, natural killer (NK) cells more efficiently recognize and lyse tumor cells and virus-infected cells.

Method of obtaining

Allostatin® is obtained through chemical synthesis.

Application

It is used in preparations with antiviral and antitumor activity and skin care products. Allostatin has undergone preclinical trials.

Patent of the Russian Federation No. 2267496